TScan Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TScan Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2024.
  • TScan Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1.25M, a 16.3% decline year-over-year.
  • TScan Therapeutics, Inc. annual Depreciation for 2023 was $5.36M, a 4.36% increase from 2022.
  • TScan Therapeutics, Inc. annual Depreciation for 2022 was $5.14M, a 54.4% increase from 2021.
  • TScan Therapeutics, Inc. annual Depreciation for 2021 was $3.33M, a 171% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.25M -$245K -16.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $1.5M +$304K +25.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $1.2M +$726K +155% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $469K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.